DEHyART Phase II Clinical Trial – Research Contribution

Awarded By: DEHyART Phase II Clinical Trial

Contributed to the DEHyART Phase II clinical trial, which evaluated FMISO PET/CT-guided dose escalation in head and neck squamous cell carcinoma, including assessment of treatment outcomes, toxicity and quality of life.

Academic & Research Contributions in Oncology

Dr. Bansal has contributed to oncology research involving molecular profiling, precision oncology, hypoxia-guided radiotherapy, treatment outcomes and cancer-related anemia, with research presented at international scientific meetings and published in peer-reviewed journals.